TSE:NTR

Nutrien Ltd. (NTR.TO)

89.35
+2.36 (2.71%)
as of Jun 30, 2026, 8:00:00 pm Market Open.
778 watching
0
Investor Insights
star iconJun 30, 2026, 12:00 am

This summary was created by AI, based on 24 opinions in the last 12 months.

Nutrien Ltd. (NTR) is viewed favorably by several experts, highlighting its stability and potential for growth amid fluctuating fertilizer prices primarily affected by geopolitical events. The company's strong capital allocation strategy, improvement in farmer balance sheets, and consistent dividend payments are seen as attractive aspects. Despite facing some volatility due to its commodity nature, many analysts believe that Nutrien is positioned well for the long term, particularly with earnings expected to grow and a competitive edge in the agriculture sector. There is also a sense of optimism regarding its valuation, with some analysts suggesting that the stock is entering a new upward trend following a period of stagnation. While there are concerns about potential overvaluation in the near term, overall sentiment remains positive, with suggestions to buy during dips.

consensus icon
Consensus
Buy
valuation icon
Valuation
Fair Value
review icon
Similar
ADM,ADM
TOP PICK
It is the premier agriculture commodity stock in the world. He likes it because the outlook for potash prices is good. They had a poor fall planting in the Midwest in south and the stock came off but he sees a good spring planting so it will be a good time to buy. (Analysts’ price target is $84.20)
PAST TOP PICK

(A Top Pick Nov 30/17, Up 12%) There are $500 million of synergies up for grabs after the big merger, which could even be higher. They are ahead of plan in synergizing. Also are selling $5 billion of non-core assets. This week in Chile, they just sold a lithium mine, generating $4 billion in cash that'll go to share buybacks and dividends. There are big gains still to come.

BUY
It's interesting now. Anytime you see an industry go through a down cycle as long as this, then a merger of two big players, that's usually positive. He likes this long-term, but short-term he expects a recession. He owns a little of this.
TOP PICK
Their Q3 beat by 10% and raised guidance as well as dividend. Well-run. He expects them to deploy $6-8 billion in coming years to drive growth. Will grow earnings 30% annually. Trades at only 13x. Solid dividend and balance sheet. (Analysts’ price target is $84.64)
BUY
They're having an up-and-down year. It's a long-term (5-10-years) play on global fertilizer demand..
BUY
b He bought a few months ago but has very little exposure to commodities. You want to own when base commodities for a company are doing well, which they are. This one is outperforming the Toronto market. It is a good one for an RESP. But keep in mind that these stocks are to be traded.
BUY
It's not far from its book value. Has good potential upside. The risks are reasonable now. He likes it.
TOP PICK

He recently bought it. Stock has fallen 10% in this recession. Expect higher divdends and buybacks to shareholdrs in the coming year. Targets mid-$70's. (3.1% Analysts price target: $82.79)

BUY

Likes it. It's the biggest crop nutriens player in the world, specifically potash and nitrogens, segments which are improving rapidly, and phosphates less so. As a condition of their merger, $5 billion assets were sold and those may be re-deployed into retail network expansion in South America like Brazil, a huge market. There's also $500 million in synergies to be captured which they are doing ahead of schedule. Expect dividend growth, acquisitions and share buybacks.

COMMENT

On one hand, people have to eat so we need potash. Others says it’s a commodity. There’s a need for inventory this year. Depends what you want to be involved in. If you want to be in the ag space, all the fund managers will own it, so its multiple will be higher.

TOP PICK

They're ahead of their cost synergies target after the potash merger. They have sold off some assets totalling $5 billion. They project $6-8 billion in free cash flow to grow their retail network to buyback 5% of the stocks and raise the dividend. They are seeing an uptick in the Nutrient business. They have signed contracts with China and India where pricing should improve next year and beyond. They will benefit from increased demand. (2.9% dividend, Analysts' price target: $81.90)

TOP PICK

This is the merger of Potash and Agrium. He wants to own commodity stocks only when the commodities are going up. Both of their main products, nitrogen and potash, have good outlooks. There is an upcoming shortage of nitrogen. They also have an agricultural retail business that stabilizes the company. Yield 2.8%. (Analysts’ price target is $81.58)

HOLD

Potash is less of a commodity than in the past. The world needs this commodity around the world. The previous supply situation globally is abating as marginal mines are not being built. This is a good name to own. He prefers to hold base metals instead, where there is even greater growth potential. Yield 2.7%.

BUY

Likes it. Nutrien has done everything it has promised after the marger. Have nicely executed a program to sell $5 billion in assets which they will invest in the retail side by doing acquisitions. They will do buybacks and raise the dividend.

PAST TOP PICK

(Past Top Pick, Nov. 30, 2017, Up 18%) He bought this two years ago at the bottom of the cycle, and now the oversupply glut is clearing and India is paying higher prices for potash. Has $5 billion in cash and will likely make accretive purchases in the future.

Showing 331 to 345 of 386 entries